Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab in Recurrent or Progressive Osteosarcoma
NCT03006848Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Feb 2017
- Primary completion
- Mar 2020
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in osteosarcoma (OS), sponsored by St. Jude Children's Research Hospital. Started Feb 2017; status: completed.
02
Drugs
avelumab
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT03006848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006848.